Old Web
English
Sign In
Acemap
>
Paper
>
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders
2021
J. Veit
Yves Poumay
D. Mendes
J Kreitinger
L. Walker
A. Paquet
C. Menigot
F. Zolezzi
Amy S. Paller
Philippe Diaz
Keywords:
Cancer research
DUAL (cognitive architecture)
Keratin
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
47
References
0
Citations
NaN
KQI
[]